Table II.
Analysis of the association between TIPE2 expression and patient clinicopathological characteristics.
| TIPE2 expression | |||||
|---|---|---|---|---|---|
| Variable | n | High, n (%) | Low, n (%) | χ2 | P-value |
| Sex | |||||
| Male | 35 | 21 (84.0) | 14 (58.3) | 3.953 | 0.0468a |
| Female | 14 | 4 (16.0) | 10 (41.7) | ||
| Age | |||||
| ≥60 | 35 | 19 (76.0) | 16 (66.7) | 0.523 | 0.4697 |
| <60 | 14 | 6 (24.0) | 8 (33.3) | ||
| TNM stage | |||||
| I–II | 30 | 12 (48.0) | 18 (75.0) | 3.760 | 0.0525 |
| III–IV | 19 | 13 (52.0) | 6 (25.0) | ||
| Lymph node metastasis | |||||
| Positive | 19 | 13 (52.0) | 6 (25.0) | 3.760 | 0.0525 |
| Negative | 30 | 12 (48.0) | 18 (75.0) | ||
| Location | |||||
| Colon | 32 | 17 (68.0) | 15 (62.5) | 0.164 | 0.6860 |
| Rectum | 17 | 8 (32.0) | 9 (37.5) | ||
| Differentiation grade | |||||
| Low | 5 | 4 (17.4) | 1 (4.5) | 1.879 | 0.1705 |
| Medium and high | 40 | 19 (82.6) | 21 (95.5) | ||
a
P<0.05. TNM, Tumor-Node-Metastasis; TIPE2, tumor necrosis factor α-induced protein 8-like 2.